BIOLOGICALS: A TEACHER’S COMPREHENSIVE GUIDE
Welcome, future pharmacists and healthcare professionals!
Biological products are large, complex molecules belonging to a varied group of products. They include blood, blood components, somatic cells, gene therapy, tissues, recombinant proteins, and vaccines; and are derived from microorganisms, plants, animals, or human cells through biotechnology.
As a pharmacology educator with years of experience teaching biological therapeutics, I have observed that students often find this topic challenging due to the complexity of these products and their mechanisms. Let me tell you: Understanding biologicals is essential for treating autoimmune diseases, cancer, rare genetic disorders, and many other conditions.
In this comprehensive guide, I will walk you through the definitions, types, indications, and side effects of biologicals. By the end of this article, you will have a thorough understanding of these essential therapeutic agents. Let us begin!
Dpharmguru’s exam insights:
Biologicals are increasingly tested in pharmacy exams. Remember: Biologicals are large, complex molecules derived from living sources. Biosimilars are highly similar to reference products. Biologicals are used in autoimmune diseases (TNF blockers), cancer (monoclonal antibodies, immunotherapies), and rare genetic diseases (enzyme replacement therapy, gene therapy). Side effects include infusion reactions, immunosuppression, and anaphylaxis. These are classic exam questions!
DEFINITIONS OF BIOLOGICALS
| Term | Definition |
|---|---|
| Biosimilar Product | Very highly similar to the reference product; no clinical differences in safety, purity, and potency |
| Interchangeable Product | Approved for substitution of another biological product without prescriber intervention; gives same clinical results |
| Non-proprietary Name | Public-domain name for a medication or biological product (unprotected by trademark) |
| Originator Biologic | Initial biological product submitted to FDA for approval; used as reference for biosimilars |
| Pharmacovigilance | Recognition, assessment, understanding, and prevention of adverse drug effects |
| Proper Name | Non-proprietary or generic name of an FDA-approved biological product |
| Proprietary Name | Trademark or brand name of a medication or biological product |
TYPES OF BIOLOGICALS
- Cells
- Allergens
- Genes
- Tissues
- Vaccines
- Blood Components
- Recombinant Proteins
INDICATIONS OF BIOLOGICALS WITH EXAMPLES
1. Biologics in Autoimmune Diseases
Some of the most commonly used biologics are used in autoimmune diseases—rheumatoid arthritis, psoriasis, Crohn’s disease, etc.
- TNF Blockers: Etanercept, Adalimumab, Infliximab—block downstream inflammatory effects of TNF-alpha (immune molecule)
- Interferon β-1a: Key treatment for multiple sclerosis
2. Biologics in Cancer Treatment
- Pembrolizumab: Biologically-designed antibody targeting a receptor on immune cells—allows destruction of cancer cells (immunotherapy)
- Trastuzumab: Interferes with signalling pathways that promote tumour growth
- Rituximab: Triggers cancer cells to destroy themselves
- Ado-trastuzumab emtansine: Linked to a toxic substance that helps destroy cancer cells
- Immune Cell Therapy: Tumour-infiltrating lymphocyte therapy, CAR-T cell therapy—collecting, altering, and re-injecting immune cells to attack tumour cells
- Laboratory-made proteins: Important class of biologics
3. Biologics in Rare Genetic Diseases
- Enzyme Replacement Therapy: Gaucher’s disease
- Blood Clotting Factors: Haemophilia
- Immunoglobulins: Certain genetic immune disorders
- Stem Cell Transplant: Rare genetic diseases, including sickle cell disease
- RNA Therapies and Gene Therapies: Under development for many rare diseases
Other Indications of Biologicals
- Rheumatoid arthritis
- Psoriasis
- Ankylosing spondylitis
- Crohn’s disease
- Multiple sclerosis
- Diabetic retinopathy
- Age-related macular degeneration
- Diabetes
- Gastric cancer
- Breast cancer
- Colon cancer
- Forms of leukaemia and lymphoma
- Infertility
- Osteoporosis
- Cystic fibrosis
- Haemophilia
- Sickle cell disease
SIDE EFFECTS OF BIOLOGICALS
Common Side Effects
- Breathlessness
- Peripheral oedema
- Headache
- Fever
- Muscle ache and pain
- Loss of appetite
- High levels of triglyceride
- Insomnia
- Pain in abdomen
- Back pain
- Dizziness
- Infusion reactions
Serious Side Effects
- Hypotension
- Anaphylaxis
- Severe infections
- Cancer
- Hypothyroidism
- Autoimmune thyroiditis
- Arterial and venous blood clots
- Congestive heart failure
- Bleeding
- Interstitial lung disease
- Hepatitis
- Generation of antibodies
- Enterocolitis
- Gastrointestinal perforation
- Anaemia
- Reduced WBC count
Dpharmguru’s exam insights:
Biologicals are frequently tested in pharmacy exams. Remember: Biosimilars are highly similar to reference products. TNF blockers (Etanercept, Adalimumab, Infliximab) are used in autoimmune diseases. Monoclonal antibodies (Pembrolizumab, Trastuzumab, Rituximab) are used in cancer. Enzyme replacement therapy is used in Gaucher’s disease. Side effects include infusion reactions, immunosuppression, and anaphylaxis. These are classic exam questions!
COMPARISON: BIOLOGICS VS SMALL MOLECULE DRUGS
| Feature | Biologics | Small Molecule Drugs |
|---|---|---|
| Size | Large, complex molecules | Small, simple molecules |
| Source | Living organisms (cells, tissues) | Chemical synthesis |
| Production | Biotechnology (cell culture) | Chemical synthesis |
| Administration | Usually injectable (IV, SC) | Usually oral |
| Immunogenicity | Can generate immune response | Rarely immunogenic |
| Examples | Vaccines, Monoclonal antibodies | Aspirin, Paracetamol |
FREQUENTLY ASKED QUESTIONS (FAQs)
1. What is the difference between a biologic and a biosimilar?
A biologic is the original, reference product. A biosimilar is a product that is highly similar to the reference biologic, with no clinically meaningful differences in safety, purity, and potency.
2. What are TNF blockers and how do they work?
TNF blockers (Etanercept, Adalimumab, Infliximab) are biologics that block the downstream inflammatory effects of TNF-alpha, an immune molecule involved in inflammation. They are used in autoimmune diseases like rheumatoid arthritis, psoriasis, and Crohn’s disease.
3. What is immunotherapy in cancer treatment?
Immunotherapy uses biologics (e.g., Pembrolizumab) to stimulate the body’s immune system to fight cancer. These drugs target specific receptors on immune cells, allowing them to destroy cancer cells more effectively.
4. What are the side effects of biologics?
Common side effects include breathlessness, headache, fever, muscle ache, infusion reactions, and loss of appetite. Serious side effects include anaphylaxis, severe infections, cancer, congestive heart failure, hepatitis, and generation of antibodies.
5. What is CAR-T cell therapy?
CAR-T cell therapy is a type of immune cell therapy where an individual’s immune cells are collected, genetically altered to recognise cancer cells, and re-injected to increase their ability to attack tumour cells.
6. What is enzyme replacement therapy?
Enzyme replacement therapy is a biologic treatment for rare genetic diseases where the patient lacks a specific enzyme. The missing enzyme is produced using biotechnology and administered to the patient (e.g., Gaucher’s disease).
SUMMARY
This comprehensive guide covered the essential aspects of biologicals:
- Definitions: Biosimilars, interchangeable products, originator biologics, pharmacovigilance
- Types: Cells, allergens, genes, tissues, vaccines, blood components, recombinant proteins
- Indications: Autoimmune diseases (TNF blockers, Interferon β-1a), Cancer (Monoclonal antibodies, Immunotherapies, CAR-T cell therapy), Rare genetic diseases (Enzyme replacement therapy, Gene therapy)
- Side Effects: Common (headache, fever, infusion reactions) and Serious (anaphylaxis, severe infections, cancer, hepatitis, generation of antibodies)
As I always tell my students: “Biologicals are revolutionizing medicine—offering new treatments for autoimmune diseases, cancer, and rare genetic disorders that were previously untreatable.”
REFERENCES AND FURTHER READING
- Pharmacy Council of India (PCI). (2022). Pharmacology Syllabus. New Delhi: PCI.
- U.S. Food and Drug Administration (FDA). (2023). Biosimilars and Biological Products. Retrieved from https://www.fda.gov.
- World Health Organization (WHO). (2022). Guidelines on Biological Products. Retrieved from https://www.who.int.
- European Medicines Agency (EMA). (2022). Biological Medicines. Retrieved from https://www.ema.europa.eu.
- Rang, H. P., & Dale, M. M. (2021). Rang & Dale’s Pharmacology (9th ed.). Elsevier.
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals for medical concerns. Pharmaceutical regulations and guidelines may vary by region—always refer to your local regulatory authorities for specific requirements.
written by:
Dr. N. Sujith Kumar
For More Study Materials, Visit: www.dpharmguru.com
